Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117265) titled 'Analysis of the Efficacy and Safety of High-Dilution Drug-Loaded Microspheres in Preventing Post-Embolization Syndrome after DEB-TACE' on Jan. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tianjin Third Central Hospital
Condition:
Disease: Hepatocellular carcinoma (HCC)
Intervention:
50-80 mL group:The drug-eluting beads were mixed with contrast medium and normal saline to a total volume of 50-80 mL.
The optimal regimen identified in phase I was selected for cohort expansion.:The drug-eluting beads were mixed with contrast medium and normal saline, with the total dilution volu...